Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center

Laryngoscope

Volumn 120, Issue 4, 2010, Pages 676-681

  Buckmiller, Lisa M ^a   Munson, Patrick D ^a   Dyamenahalli, Umesh ^a   Dai, Yuemeng ^b   Richter, Gresham T ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Beta blocker; Birthmark; Hemangioma; Propranolol

Indexed keywords

PROPRANOLOL DERIVATIVE; STEROID; VINCRISTINE;

ADJUVANT THERAPY; AIRWAY OBSTRUCTION; ALLERGIC RASH; BLEEDING; BRONCHOSPASM; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CARBON DIOXIDE LASER; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYE LASER; EXCISION; FEMALE; FLASH PULSED DYE LASER; GASTROESOPHAGEAL REFLUX; HEART DISEASE; HEMANGIOMA; HUMAN; HYPOGLYCEMIA; INFANT; INFANT DISEASE; MALE; MEDICAL DOCUMENTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSORIATIC LIKE RASH; PTOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SOMNOLENCE; STEROID THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER; VIRUS INFECTION;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ARKANSAS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HOSPITALS, SPECIAL; HUMANS; INFANT; MALE; PHOTOGRAPHY; PROPRANOLOL; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77950821582     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20807     Document Type: Review

References (15)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69:412-422. (Pubitemid 12191292)
2. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-367.
3. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999;341:173-181.
4. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150:291-294. (Pubitemid 46328964)
5. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118:882-887. (Pubitemid 46091612)
6. Fawcett SL, Grant I, Hall PN, Kelsall AW, Nicholson JC. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 2004;57: 168-171. (Pubitemid 38239893)
7. Perez J, Pardo J, Gomez C. Vincristine-an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol 2002;41:197-199. (Pubitemid 34557083)
8. Pransky SM, Canto C. Management of subglottic hemangioma. Curr Opin Otolaryngol Head Neck Surg 2004;12: 509-512. (Pubitemid 39565206)
9. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358: 2649-2651. (Pubitemid 351831393)
10. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 2009;119:2051-2054.
11. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-1172.
12. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359: 2846; author reply 2846-2847.
13. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP. Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009 Apr 9 [Epub ahead of print].
14. Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg 1982;70:120-121.
15. Zhang D, Ma Q, Shen S, Hu H. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: The study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Pancreas 2009;38:94-100.